[go: up one dir, main page]

PL1835907T3 - Leki do leczenia lub zapobiegania chorobom zwłóknieniowym - Google Patents

Leki do leczenia lub zapobiegania chorobom zwłóknieniowym

Info

Publication number
PL1835907T3
PL1835907T3 PL05823903T PL05823903T PL1835907T3 PL 1835907 T3 PL1835907 T3 PL 1835907T3 PL 05823903 T PL05823903 T PL 05823903T PL 05823903 T PL05823903 T PL 05823903T PL 1835907 T3 PL1835907 T3 PL 1835907T3
Authority
PL
Poland
Prior art keywords
medicaments
prevention
treatment
fibrotic diseases
fibrotic
Prior art date
Application number
PL05823903T
Other languages
English (en)
Inventor
John Edward Park
Nveed Chaudhary
Gerald Jürgen Roth
Armin Heckel
Thorsten Lehmann-Lintz
Jörg Kley
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PL1835907T3 publication Critical patent/PL1835907T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL05823903T 2004-12-24 2005-12-21 Leki do leczenia lub zapobiegania chorobom zwłóknieniowym PL1835907T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04030769 2004-12-24
PCT/EP2005/057013 WO2006067175A1 (en) 2004-12-24 2005-12-21 Medicaments for the treatment or prevention of fibrotic diseases
EP05823903A EP1835907B1 (en) 2004-12-24 2005-12-21 Medicaments for the treatment or prevention of fibrotic diseases

Publications (1)

Publication Number Publication Date
PL1835907T3 true PL1835907T3 (pl) 2009-08-31

Family

ID=35717457

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05823903T PL1835907T3 (pl) 2004-12-24 2005-12-21 Leki do leczenia lub zapobiegania chorobom zwłóknieniowym

Country Status (26)

Country Link
US (3) US20060148883A1 (pl)
EP (1) EP1835907B1 (pl)
JP (1) JP5748386B2 (pl)
KR (1) KR20070092305A (pl)
CN (1) CN101087604B (pl)
AR (1) AR052439A1 (pl)
AT (1) ATE429222T1 (pl)
AU (1) AU2005318136B2 (pl)
BR (1) BRPI0519351A2 (pl)
CA (1) CA2591089C (pl)
DE (1) DE602005014145D1 (pl)
DK (1) DK1835907T3 (pl)
EA (1) EA200701181A1 (pl)
ES (1) ES2326277T3 (pl)
HR (1) HRP20090312T1 (pl)
IL (1) IL184124A0 (pl)
MX (1) MX2007007676A (pl)
NO (1) NO20073830L (pl)
PE (1) PE20061155A1 (pl)
PL (1) PL1835907T3 (pl)
PT (1) PT1835907E (pl)
RS (1) RS50833B (pl)
SI (1) SI1835907T1 (pl)
TW (1) TW200637544A (pl)
WO (1) WO2006067175A1 (pl)
ZA (1) ZA200703600B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7514468B2 (en) * 2002-07-23 2009-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
US7169936B2 (en) * 2002-07-23 2007-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
WO2007057399A2 (en) * 2005-11-15 2007-05-24 Boehringer Ingelheim International Gmbh Treatment of cancer with indole derivatives
JP5174802B2 (ja) * 2007-03-02 2013-04-03 三井化学株式会社 不織布積層体
EP2220079A2 (en) * 2007-11-15 2010-08-25 Boehringer Ingelheim International GmbH Substituted amides, manufacturing and use thereof as medicaments
US20090131359A1 (en) * 2007-11-19 2009-05-21 Atamas Sergei P Antifibrotic therapy
NZ586867A (en) * 2008-01-25 2012-05-25 Boehringer Ingelheim Int Crystalline 4-[(Z)-[[4-[(dimethylamino)methyl]phenyl]amino](6-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-benzenepropanoic acid monohydrochloride hemihydrate
JP2012503619A (ja) * 2008-09-26 2012-02-09 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル Hcv感染に対する抗ウイルス治療のための標的としての宿主細胞キナーゼ
US20140050728A1 (en) * 2011-01-28 2014-02-20 Board Of Regents Of The University Of Nebraska Methods and compositions for inhibiting cyclophilin d for the treatment and prevention of obesity and kidney indications
US10450295B2 (en) 2013-08-09 2019-10-22 Acclaim BioMed USA LLC Method of using an indolinone molecule and derivatives for inhibiting liver fibrosis and hepatitis
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
PT3691620T (pt) 2017-10-05 2022-10-06 Fulcrum Therapeutics Inc Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL346898A1 (en) * 1998-09-25 2002-03-11 Boehringer Ingelheim Pharma Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
US6762180B1 (en) * 1999-10-13 2004-07-13 Boehringer Ingelheim Pharma Kg Substituted indolines which inhibit receptor tyrosine kinases
DE10117204A1 (de) * 2001-04-06 2002-10-10 Boehringer Ingelheim Pharma In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US7169936B2 (en) * 2002-07-23 2007-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
PE20040701A1 (es) * 2002-07-23 2004-11-30 Boehringer Ingelheim Pharma Derivados de indolinona sustituidos en posicion 6 y su preparacion como medicamentos

Also Published As

Publication number Publication date
JP5748386B2 (ja) 2015-07-15
MX2007007676A (es) 2007-08-14
CA2591089A1 (en) 2006-06-29
WO2006067175A1 (en) 2006-06-29
ZA200703600B (en) 2008-07-30
AR052439A1 (es) 2007-03-21
BRPI0519351A2 (pt) 2009-01-20
KR20070092305A (ko) 2007-09-12
AU2005318136A1 (en) 2006-06-29
JP2008525374A (ja) 2008-07-17
DE602005014145D1 (de) 2009-06-04
US20120004202A1 (en) 2012-01-05
CN101087604A (zh) 2007-12-12
IL184124A0 (en) 2007-10-31
DK1835907T3 (da) 2009-08-03
RS50833B (sr) 2010-08-31
US20140128409A1 (en) 2014-05-08
ATE429222T1 (de) 2009-05-15
CA2591089C (en) 2014-02-11
CN101087604B (zh) 2010-10-13
PT1835907E (pt) 2009-06-16
AU2005318136B2 (en) 2012-02-09
EP1835907B1 (en) 2009-04-22
EP1835907A1 (en) 2007-09-26
NO20073830L (no) 2007-07-23
ES2326277T3 (es) 2009-10-06
HRP20090312T1 (hr) 2009-07-31
PE20061155A1 (es) 2006-12-16
US20060148883A1 (en) 2006-07-06
EA200701181A1 (ru) 2008-02-28
SI1835907T1 (sl) 2009-10-31
TW200637544A (en) 2006-11-01

Similar Documents

Publication Publication Date Title
IL184125A0 (en) Medicaments for the treatment or prevention of fibrotic diseases
IL184124A0 (en) Medicaments for the treatment or prevention of fibrotic diseases
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
GB0410399D0 (en) The treatment of respiratory disease
GB0410398D0 (en) The treatment of respiratory disease
PL1670482T3 (pl) Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
DE602005014141D1 (de) Medikamente zur behandlung oder prävention fibrotischer krankheiten
GB0523961D0 (en) The treatment of ophthalmic diseases
GB0425854D0 (en) Therapeutic treatment
GB0408752D0 (en) Therapeutic treatment
GB0523964D0 (en) The treatment of ophthalmic diseases
ZA200606780B (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
GB0420867D0 (en) Compounds for the treatment of diseases
GB0407710D0 (en) Treatment of diseases
GB0425064D0 (en) Compounds useful for the treatment of diseases
AP2006003743A0 (en) Compounds useful for the treatment of diseases
GB0418556D0 (en) The treatment of pain
GB0415267D0 (en) The treatment of pain
GB0404339D0 (en) Therapeutic treatment
GB0425281D0 (en) Therapeutic treatment
GB0404358D0 (en) Therapeutic treatment
GB0420265D0 (en) Therapeutic treatment